Generic tacrolimus

DRUG3 trials

Sponsors

Novartis, Vastra Gotaland Region, Sandoz

Conditions

Kidney TransplantRenal TransplantRenal Transplantation

Phase 1

Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in Stable Kidney Transplant Patients.

WithdrawnNCT03978494

SandozKidney Transplant

Start: 2019-09-02End: 2020-05-03Updated: 2019-09-17

Phase 4

Pharmacokinetics of Generic to Brand Tacrolimus in Stable Renal Transplant Patients

CompletedNCT01256294

NovartisRenal Transplant

Start: 2010-10-31End: 2011-05-31Updated: 2012-06-21

Unknown Phase

A 1-year Comparison of Generic Tacrolimus (Tacni) and Prograf in Renal Transplant Patients - a Retrospective Matched Pair Analysis, GenTac

CompletedNCT02587052

Vastra Gotaland RegionRenal Transplantation

Start: 2015-10-31End: 2016-12-31Updated: 2021-02-03